Johnson & Johnson Analyst Price Targets

Johnson & Johnson

JNJNYSE

$264.74

-2.83-1.06%

al cierre: Sep 30, 5:00 PM EST

$265.09

0.350.13%

After hour: 7:47 PM EST

Ganancias: Beneficios de Q3 2026 dentro de 13 días de ahora en mar oct 13th, antes de la apertura del mercado

Wall Street analyst price targets and consensus rating for Johnson & Johnson (JNJ).

Price Target Range — 8 Quarters

Analyst Consensus — 17 Analysts

11Buy

6Hold

Consensus RatingBuy# Analysts17Avg. Consensus PT$264Upside to Avg. PT-0.5%

Rating Trend — Last 9 Months

Date	Firm	Analyst	Action	Rating Change	Price Target
Sep 29, 2026	JP Morgan	Chris Schott	PT Raise	Neutral	$270→$285
Sep 10, 2026	HSBC	Rajesh Kumar	PT Raise	Buy	$290→$320
Sep 2, 2026	UBS	Michael Yee	PT Raise	Buy	$280→$320
Aug 6, 2026	Guggenheim	Vamil Divan	PT Raise	Buy	$270→$287
Aug 3, 2026	Wells Fargo	Larry Biegelsen	PT Raise	Overweight	$272→$282
Jul 17, 2026	Guggenheim	Vamil Divan	Maintained	Buy	$270
Jul 16, 2026	Raymond James	Jayson Bedford	PT Raise	Outperform	$258→$265
Jul 16, 2026	RBC Capital	Shagun Singh	Maintained	Outperform	$287
Jul 16, 2026	Wells Fargo	Larry Biegelsen	PT Raise	Overweight	$263→$272
Jul 16, 2026	Morgan Stanley	Terence Flynn	PT Raise	Overweight	$284→$294
Jul 13, 2026	TD Cowen	Michael Nedelcovych	PT Raise	Buy	$250→$300
Jul 13, 2026	RBC Capital	Shagun Singh	PT Raise	Outperform	$265→$287
Jul 10, 2026	B of A Securities	Tim Anderson	PT Raise	Neutral	$254→$263
Jul 8, 2026	Morgan Stanley	Terence Flynn	PT Raise	Overweight	$283→$284
Jul 8, 2026	Citigroup	Joanne Wuensch	PT Raise	Buy	$285→$298
Jun 26, 2026	Guggenheim	Vamil Divan	PT Raise	Buy	$266→$270
May 13, 2026	Leerink Partners	David Risinger	Upgrade	Market Perform→Outperform	$265
Apr 15, 2026	Barclays	Matt Miksic	PT Raise	Equal-Weight	$234→$255
Apr 15, 2026	Stifel	Rick Wise	PT Raise	Hold	$220→$250
Apr 15, 2026	Wells Fargo	Larry Biegelsen	PT Raise	Overweight	$240→$263